{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:00:22Z","timestamp":1757624422847,"version":"3.44.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Deep mycoses, largely caused by mycetoma and chromoblastomycosis, is a chronic fungal infection prevalent in tropics and subtropics regions. Deprived populations in these regions are disproportionately affected. However, control strategies for deep mycoses on a global scale remain limited even though these diseases are included in WHO\u2019s roadmap for 2021\u20132030 NTDs. China and Rwanda, with distinct climates, economic conditions and health systems and policies, are both burdened with this debilitating fungal infection. This review, therefore, focused on providing a cross-case evaluation of the control strategies for mycetoma and chromoblastomycosis in Rwanda and China by assessing their epidemiology, diagnostics, treatment accessibility and policy frameworks in an effort to find actionable strategies for elimination. Evidence in the control strategies in these different countries can help improve the management of deep mycoses. Rwanda can learn more about advanced diagnostic technologies from China, while China may benefit from adapting the community-based approach from Rwanda. Enhancing surveillance, declaring mycetoma as notifiable disease, and encouraging international cooperation are essential for meeting the WHO 2030 NTD elimination targets.<\/jats:p>","DOI":"10.1186\/s41182-025-00778-6","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:00:10Z","timestamp":1756105210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bridging gaps in the elimination of deep mycoses: a comparative analysis of mycetoma and chromoblastomycosis control strategies in Rwanda and China"],"prefix":"10.1186","volume":"53","author":[{"given":"Alieu","family":"Sam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niyibizi","family":"Julius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munawar Harun","family":"Koray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"1","key":"778_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13693780802538001","volume":"47","author":"F Queiroz-Telles","year":"2009","unstructured":"Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47(1):3\u201315.","journal-title":"Med Mycol"},{"issue":"1","key":"778_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1473-3099(15)00359-X","volume":"16","author":"EE Zijlstra","year":"2016","unstructured":"Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016;16(1):100\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"778_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009611","volume":"15","author":"D Santos","year":"2021","unstructured":"Santos D, de Azevedo C, Vicente VA, Queiroz-Telles F, Rodrigues AM, de Hoog GS, et al. The global burden of chromoblastomycosis. PLoS Negl Trop Dis. 2021;15(8): e0009611.","journal-title":"PLoS Negl Trop Dis"},{"key":"778_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002550","volume":"7","author":"WW van de Sande","year":"2013","unstructured":"van de Sande WW. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7: e2550.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"778_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012562","volume":"18","author":"DJ Smith","year":"2024","unstructured":"Smith DJ, Queiroz-Telles F, Rabenja FR, Hay R, Bonifaz A, Grijsen ML, et al. A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group. PLoS Negl Trop Dis. 2024;18(10): e0012562.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"778_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40249-024-01223-2","volume":"13","author":"CB Butala","year":"2024","unstructured":"Butala CB, Cave RNR, Fyfe J, Coleman PG, Yang GJ, Welburn SC. Impact of COVID-19 on the neglected tropical diseases: a scoping review. Infect Dis Poverty. 2024;13(1):55.","journal-title":"Infect Dis Poverty"},{"issue":"10","key":"778_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/trstmh\/trae016","volume":"118","author":"A Fahal","year":"2024","unstructured":"Fahal A, Smith DJ, Nyaoke B, Asiedu K, Falves F, Warusavithanas S, et al. Towards enhanced control of mycetoma: a roadmap to achieve the UN\u2019s sustainable development goals by 2030. Trans R Soc Trop Med Hyg. 2024;118(10):646\u201351.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"778_CR8","unstructured":"WHO. WHO fungal priority pathogens list to guide research, development and public health action. 2022."},{"issue":"4","key":"778_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2017;3(4):57.","journal-title":"J Fungi (Basel)."},{"issue":"suppl_1","key":"778_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/mmy\/myx104","volume":"56","author":"S Seyedmousavi","year":"2018","unstructured":"Seyedmousavi S, Bosco SMG, de Hoog S, Ebel F, Elad D, Gomes RR, et al. Fungal infections in animals: a patchwork of different situations. Med Mycol. 2018;56(suppl_1):165\u201387.","journal-title":"Med Mycol"},{"issue":"8","key":"778_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009964","volume":"16","author":"JB Ntivuguruzwa","year":"2022","unstructured":"Ntivuguruzwa JB, Michel AL, Kolo FB, Mwikarago IE, Ngabonziza JCS, van Heerden H. Prevalence of bovine tuberculosis and characterization of the members of the Mycobacterium tuberculosis complex from slaughtered cattle in Rwanda. PLoS Negl Trop Dis. 2022;16(8): e0009964.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"778_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/QCO.0000000000000870","volume":"35","author":"C Seas","year":"2022","unstructured":"Seas C, Legua P. Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach. Curr Opin Infect Dis. 2022;35(5):379\u201383.","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"778_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.21037\/atm-21-6119","volume":"10","author":"Y Shen","year":"2022","unstructured":"Shen Y, Jiang B, Zhang H, Feng J, Hua H. Combination therapy for an elderly patient with chromoblastomycosis caused by Fonsecaea monophora: a case report. Ann Transl Med. 2022;10(2):114.","journal-title":"Ann Transl Med"},{"issue":"9","key":"778_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010800","volume":"16","author":"S Liu","year":"2022","unstructured":"Liu S, Zhi H, Shen H, Lv W, Sang B, Li Q, et al. Chromoblastomycosis: a case series from Eastern China. PLoS Negl Trop Dis. 2022;16(9): e0010800.","journal-title":"PLoS Negl Trop Dis"},{"key":"778_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.105679","volume":"80","author":"I Sibomana","year":"2021","unstructured":"Sibomana I, Ishimwe M, Maniriho B, Nyampinga C, Ruhangaza D, Gahemba I. Actinomycetoma of the colon presenting as abdominal wall abscess. Case report and review of the literature. Int J Surg Case Rep. 2021;80: 105679.","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"778_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jaad.2004.10.883","volume":"53","author":"O Lupi","year":"2005","unstructured":"Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005;53(6):931\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"778_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007964","volume":"14","author":"ML Rodrigues","year":"2020","unstructured":"Rodrigues ML, Nosanchuk JD. Fungal diseases as neglected pathogens: a wake-up call to public health officials. PLoS Negl Trop Dis. 2020;14(2): e0007964.","journal-title":"PLoS Negl Trop Dis"},{"key":"778_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-015-0443-z","volume":"13","author":"S Nsanzimana","year":"2015","unstructured":"Nsanzimana S, Prabhu K, McDermott H, Karita E, Forrest JI, Drobac P, et al. Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experience. BMC Med. 2015;13:216.","journal-title":"BMC Med"},{"issue":"5\u20136","key":"778_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11046-012-9586-z","volume":"175","author":"S Lu","year":"2013","unstructured":"Lu S, Lu C, Zhang J, Hu Y, Li X, Xi L. Chromoblastomycosis in Mainland China: a systematic review on clinical characteristics. Mycopathologia. 2013;175(5\u20136):489\u201395.","journal-title":"Mycopathologia"},{"issue":"4","key":"778_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/trstmh\/traa184","volume":"115","author":"WWJ van de Sande","year":"2021","unstructured":"van de Sande WWJ. In vitro susceptibility testing for black grain eumycetoma causative agents. Trans R Soc Trop Med Hyg. 2021;115(4):343\u201354.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"778_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005509","volume":"11","author":"AH Fahal","year":"2017","unstructured":"Fahal AH. Mycetoma: a global medical and socio-economic dilemma. PLoS Negl Trop Dis. 2017;11(4): e0005509.","journal-title":"PLoS Negl Trop Dis"},{"key":"778_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107812","volume":"152","author":"C Karutu","year":"2025","unstructured":"Karutu C, Ansumana R, de Souza DK, Njenga S, Coulibaly YI, Lee SS, et al. Towards elimination of Neglected Tropical Diseases: strengthening partnerships, fostering collaboration, and promoting country ownership. Int J Infect Dis. 2025;152: 107812.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"778_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/jof10090658","volume":"10","author":"CM Muvunyi","year":"2024","unstructured":"Muvunyi CM, Ngabonziza JCS, Florence M, Mukagatare I, Twagirumukiza M, Ahmed A, et al. Diversity and distribution of fungal infections in Rwanda: high risk and gaps in knowledge, policy, and interventions. J Fungi (Basel). 2024;10(9):658.","journal-title":"J Fungi (Basel)"},{"key":"778_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.107799","volume":"152","author":"N Ladislas","year":"2025","unstructured":"Ladislas N, Aimable M, Alison O, Mbonigaba JB, Ursin B, Johannes W, et al. From mapping to elimination: a comprehensive overview of Rwanda\u2019s schistosomiasis program. Int J Infect Dis. 2025;152: 107799.","journal-title":"Int J Infect Dis"},{"key":"778_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2023.100620","volume":"43","author":"T Yang","year":"2024","unstructured":"Yang T, Ding Y, Fu Y, Chen H. The first case of subcutaneous mycosis caused by Muyocopron laterale in China. Med Mycol Case Rep. 2024;43: 100620.","journal-title":"Med Mycol Case Rep"},{"issue":"2","key":"778_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11046-019-00324-z","volume":"184","author":"R Wang","year":"2019","unstructured":"Wang R, Yao X, Li R. Mycetoma in China: a case report and review of the literature. Mycopathologia. 2019;184(2):327\u201334.","journal-title":"Mycopathologia"},{"issue":"3","key":"778_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4269\/ajtmh.23-0573","volume":"112","author":"X Hu","year":"2025","unstructured":"Hu X, Zhang M, Lv S, Liu Z, Nakagawa I, Li F. Eumycetoma caused by aspergillus terreus: a case report and literature review. Am J Trop Med Hyg. 2025;112(3):548\u201352.","journal-title":"Am J Trop Med Hyg"},{"key":"778_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.984093","volume":"13","author":"C Huang","year":"2022","unstructured":"Huang C, Deng W, Zhang Y, Zhang K, Ma Y, Song Y, et al. CARD9 deficiency predisposing chromoblastomycosis: a case report and comparative transcriptome study. Front Immunol. 2022;13: 984093.","journal-title":"Front Immunol"},{"issue":"6","key":"778_CR29","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.4269\/ajtmh.21-0735","volume":"105","author":"XW Huang","year":"2021","unstructured":"Huang XW, Xu MN, Dai SQ, Zeng K, Li L. Case report: short-term application of topical imiquimod is practical for chromoblastomycosis. Am J Trop Med Hyg. 2021;105(6):1696\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"778_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.810604","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Sun J, Li M, Cai W, Chen Y, Liu Y, et al. Molecular characteristics of regional chromoblastomycosis in Guangdong, China: epidemiological, clinical, antifungal susceptibility, and serum cytokine profiles of 45 cases. Front Cell Infect Microbiol. 2022;12: 810604.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"778_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/13693780802468209","volume":"47","author":"L Xi","year":"2009","unstructured":"Xi L, Sun J, Lu C, Liu H, Xie Z, Fukushima K, et al. Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China. Med Mycol. 2009;47(1):27\u201333.","journal-title":"Med Mycol"},{"issue":"1","key":"778_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","volume":"12","author":"M Chen","year":"2018","unstructured":"Chen M, Xu Y, Hong N, Yang Y, Lei W, Du L, et al. Epidemiology of fungal infections in China. Front Med. 2018;12(1):58\u201375.","journal-title":"Front Med"},{"issue":"1","key":"778_CR33","doi-asserted-by":"publisher","first-page":"20241132","DOI":"10.1515\/med-2024-1132","volume":"20","author":"W Chen","year":"2025","unstructured":"Chen W, Wu X, Yaqoob MD, Liu K, Hu Y, Ke X, et al. Analysis of the effect of ALA-PDT on macrophages in footpad model of mice infected with Fonsecaea monophora based on single-cell sequencing. Open Med (Wars). 2025;20(1):20241132.","journal-title":"Open Med (Wars)"},{"issue":"7","key":"778_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/jof8070743","volume":"8","author":"X Hao","year":"2022","unstructured":"Hao X, Cognetti M, Burch-Smith R, Mejia EO, Mirkin G. Mycetoma: development of diagnosis and treatment. J Fungi (Basel). 2022;8(7):743.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"778_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4269\/ajtmh.24-0651","volume":"112","author":"Y Li","year":"2025","unstructured":"Li Y, Song Y, Wang A. Successful treatment of chromoblastomycosis caused by cladophialophora carrionii with itraconazole: clinicopathology, susceptibility, and molecular identification of a case in Northern China. Am J Trop Med Hyg. 2025;112(4):865\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"778_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mib.2021.05.005","volume":"62","author":"Y Ma","year":"2021","unstructured":"Ma Y, Wang X, Li R. Cutaneous and subcutaneous fungal infections: recent developments on host\u2013fungus interactions. Curr Opin Microbiol. 2021;62:93\u2013102.","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"778_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s15010-020-01437-0","volume":"49","author":"L Wei","year":"2021","unstructured":"Wei L, Yu J. Chromoblastomycosis caused by Cladophialophora carrionii. Infection. 2021;49(3):567\u20138.","journal-title":"Infection"},{"issue":"2","key":"778_CR38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4269\/ajtmh.19-0465","volume":"103","author":"B Dong","year":"2020","unstructured":"Dong B, Liu W, Li R, Chen Y, Tong Z, Zhang X, et al. Muriform Cells Can Reproduce by Dividing in an Athymic Murine Model of Chromoblastomycosis due to Fonsecaea pedrosoi. Am J Trop Med Hyg. 2020;103(2):704\u201312.","journal-title":"Am J Trop Med Hyg"},{"key":"778_CR39","doi-asserted-by":"publisher","first-page":"1520608","DOI":"10.3389\/fcimb.2025.1520608","volume":"15","author":"Q Yu","year":"2025","unstructured":"Yu Q, Li L, Wang Y, Gao Z, Liu S, Tan J, et al. Clinical experience of primary subcutaneous mycoses in Shanghai: a retrospective analysis. Front Cell Infect Microbiol. 2025;15:1520608.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"778_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12941-024-00718-y","volume":"23","author":"J Zheng","year":"2024","unstructured":"Zheng J, Liu S, Xie Z, Chen Y, Xi L, Liu H, et al. Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy. Ann Clin Microbiol Antimicrob. 2024;23(1):57.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"778_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40249-019-0599-4","volume":"8","author":"MB Qian","year":"2019","unstructured":"Qian MB, Chen J, Bergquist R, Li ZJ, Li SZ, Xiao N, et al. Neglected tropical diseases in the People\u2019s Republic of China: progress towards elimination. Infect Dis Poverty. 2019;8(1):86.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"778_CR42","volume":"6","author":"M Xiao","year":"2025","unstructured":"Xiao M, Zhang L, Wang Y, Feng J, Kong W, Lin L, et al. China\u2019s innovative national plan to combat fungal diseases and antifungal resistance. Innovation (Camb). 2025;6(1): 100741.","journal-title":"Innovation (Camb)"},{"key":"778_CR43","unstructured":"World Health OW. Ending the neglect to attain the Sustainable Development Goals A road map for neglected tropical diseases 2021\u20132030. WORLD HEALTH ORGANIZATION (WHO); 2020 2020."},{"issue":"3","key":"778_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1473-3099(15)00360-6","volume":"16","author":"J Xu","year":"2016","unstructured":"Xu J, Yu Q, Tchuente LA, Bergquist R, Sacko M, Utzinger J, et al. Enhancing collaboration between China and African countries for schistosomiasis control. Lancet Infect Dis. 2016;16(3):376\u201383.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"778_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002550","volume":"7","author":"WW van de Sande","year":"2013","unstructured":"van de Sande WW. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(11): e2550.","journal-title":"PLoS Negl Trop Dis"},{"issue":"15","key":"778_CR46","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/diagnostics14151664","volume":"14","author":"S Naik","year":"2024","unstructured":"Naik S, Kashyap D, Deep J, Darwish S, Cross J, Mansoor E, et al. Utilizing next-generation sequencing: advancements in the diagnosis of fungal infections. Diagnostics (Basel). 2024;14(15):1664.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"778_CR47","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","volume":"21","author":"Y Sun","year":"2015","unstructured":"Sun Y, Meng F, Han M, Zhang X, Yu L, Huang H, et al. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Biol Blood Marrow Transplant. 2015;21(6):1117\u201326.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"778_CR48","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/ijerph18041941","volume":"18","author":"A Barry","year":"2021","unstructured":"Barry A, Olsson S, Khaemba C, Kabatende J, Dires T, Fimbo A, et al. Comparative assessment of the pharmacovigilance systems within the neglected tropical diseases programs in east Africa-Ethiopia, Kenya, Rwanda, and Tanzania. Int J Environ Res Public Health. 2021;18(4):1941.","journal-title":"Int J Environ Res Public Health"},{"key":"778_CR49","unstructured":"Fund E. Partnering to End Neglected Tropical Diseases in Rwanda. END Fund: END Fund; 2018."},{"key":"778_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012562","volume":"18","author":"DJ Smith","year":"2024","unstructured":"Smith DJ, Queiroz-Telles F, Rabenja FR, Hay R, Bonifaz A, Grijsen ML, et al. A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group. PLoS Negl Trop Dis. 2024;18: e0012562.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"778_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12936-025-05278-w","volume":"24","author":"A Umugwaneza","year":"2025","unstructured":"Umugwaneza A, Mutsaers M, Ngabonziza JCS, Kattenberg JH, Uwimana A, Ahmed A, et al. Half-decade of scaling up malaria control: malaria trends and impact of interventions from 2018 to 2023 in Rwanda. Malar J. 2025;24(1):40.","journal-title":"Malar J"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00778-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00778-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:49:12Z","timestamp":1757425752000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00778-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00778-6","relation":{},"ISSN":["1349-4147"],"issn-type":[{"type":"electronic","value":"1349-4147"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This review does not require registry as no protocols was established.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocols and registry"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}